Alvar Aallon katu 1
P.O. Box 380
00101 Helsinki, Finland
Stay up to date with UPM Biomedicals
Our latest press releases
UPM Biomedicals to advance cancer immunotherapies in Finnish Cancer IO project
(UPM, Helsinki, 19 May 2020 at 10:00 EET) – UPM Biomedicals takes part in a new cancer immunotherapy focused top-level collaborative research and innovation project, Cancer IO. The Cancer IO project starts as part of Business Finland’s Personalize...
New Director for UPM Biomedicals
(UPM, Helsinki, 4 May 2020) - Johana Kuncova-Kallio has been appointed Director, UPM Biomedicals as of 4 of May 2020. She will be responsible for leading and developing UPM Biomedicals business. Johana is joining UPM from BioNavis Ltd where she h...
UPM and Nichirei Biosciences announce partnership to supply Japanese 3D cell culture market with GrowDex® advanced natural hydrogels
(UPM, Helsinki, 13 March 2020 at 09:00 EET) - UPM Biomedicals and Nichirei Biosciences Inc. have signed an agreement on 1 March, 2020 to offer the full range of UPM cell culture products to life sciences researchers in Japan. This agreement will...
UPM joins the new consortium to investigate theranostic potential of extracellular vesicles
(UPM, Helsinki, 17 February 2020 at 11:00 EET) UPM has joined a newly formed Finnish research consortium that plans to use extracellular vesicles to develop novel nano-biotechnological solutions for the early diagnostics and treatment of severe...